002513 蓝丰生化
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)325.624-173.591-62.622-53.7841.290
总资产报酬率 ROA (%)-4.077-13.631-20.021-24.3220.591
投入资产回报率 ROIC (%)-11.296-33.734-40.021-36.4880.908

边际利润分析
销售毛利率 (%)-2.438-2.0500.652-0.32813.724
营业利润率 (%)-23.588-19.905-12.487-36.831-0.516
息税前利润/营业总收入 (%)-24.837-18.793-16.619-35.3273.069
净利润/营业总收入 (%)-20.907-19.966-22.190-34.0181.105

收益指标分析
经营活动净收益/利润总额(%)65.42571.56648.21437.949-2,032.334
价值变动净收益/利润总额(%)-0.275-8.923-0.935-0.3321,327.402
营业外收支净额/利润总额(%)11.2402.16226.9301.308350.074

偿债能力分析
流动比率 (X)0.5380.6260.3470.5220.726
速动比率 (X)0.4260.5590.2530.3950.611
资产负债率 (%)97.75792.62775.76661.42049.810
带息债务/全部投入资本 (%)79.05281.30231.71128.907--
股东权益/带息债务 (%)-12.2972.337175.560240.144209.014
股东权益/负债合计 (%)-3.2970.80131.98662.812100.762
利息保障倍数 (X)-14.295-12.111-35.379-17.7381.072

营运能力分析
应收账款周转天数 (天)62.21247.41321.56115.7740.000
存货周转天数 (天)47.02326.92128.92832.6100.000